Ferritin Quantitative Test

C-peptide Rapid Quantitative Test (Chemiluminescence Immunoassay)

C-peptide Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the C-peptide concentration in human serum and plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of diabetes diseases.

Product Detail

Application

C-peptide is a substance produced by the pancreas, along with insulin. Insulin is a hormone that controls the body's glucose (blood sugar) levels. Glucose is the primary source of energy for the body. If the body does not produce the appropriate amount of insulin, it may be an indication of diabetes.

 

C-peptide and insulin are released from the pancreas simultaneously and in approximately equal amounts. As a result, a C-peptide test can provide insights into the body's insulin production levels. This test can be a useful way to measure insulin levels because C-peptide tends to remain in the body for a longer duration compared to insulin.

 

The key advantage of using a C-peptide test is that it can offer a more accurate assessment of the body's insulin production capacity. Insulin itself is cleared from the bloodstream relatively quickly, making it more challenging to measure. In contrast, C-peptide has a longer half-life, providing a more reliable indicator of the pancreas's insulin-producing capabilities.

 

By analyzing C-peptide levels, healthcare providers can gain valuable information about the underlying cause of a patient's diabetes, which can inform the most appropriate treatment approach. This test can be particularly useful in differentiating between type 1 and type 2 diabetes, as well as in monitoring the progression of the disease and the effectiveness of insulin therapy.

 

In summary, the C-peptide test provides a valuable tool for healthcare professionals to assess and manage diabetes by offering insights into the body's insulin production and secretion dynamics.

 

Product Specification

Sample Volume

WB: 20μL; Serum/Plasma: 10μL

Test Time

10 mins

Measuring Range

0.1- 40.00 ng/mL

Pack

20T40T100T

Storage

2~30

 

Features

Smart - Photosensitive and Luminescent Microspheres

Rapid - Whole Blood Sample Type Supported & No Centrifuge Needed

Convenient - Room Temperature Storage & Minimal sample consumption

 

Clinical significance

Assessment of Endogenous Insulin Production

Distinguishing Type 1 and Type 2 Diabetes

Monitoring Islet Cell Transplants

Assessment of Insulinoma

Evaluation of Hypoglycemia

 

Leave A Message

Please provide us with the information below, and we'll contact you as soon as possible.

Related Products
HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay)
HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay)
HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Glycated hemoglobin A1c (HbA1c) concentration in human whole blood that contains EDTA or without anticoagulants samples, mainly used for the supervising of long-term glycemic control in diabetic individuals and auxiliary diagnosis of diabetes and identify patients at risk of diabetes.
INS Rapid Quantitative Test (Chemiluminescence Immunoassay)
INS Rapid Quantitative Test (Chemiluminescence Immunoassay)
INS Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Insulin (INS) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of diabetes diseases.
Dengue IgG/IgM Antibody Rapid Qualitative Test (Fluorescence Immunoassay)
Dengue IgG/IgM Antibody Rapid Qualitative Test (Fluorescence Immunoassay)
The Biotime DengueIgG/IgM Antibody Rapid Testis intended to qualitatively detect the dengue IgG/IgM antibody in human serum, plasma or whole blood samples on Biotime FIA Analyzer byfluorescent immunoassay. The test is used asthe early aid diagnosis and screening of dengue virus infection. For in vitro diagnostic use only. For professional use only.
Myo Rapid Quantitative Test (Chemiluminescence Immunoassay)
Myo Rapid Quantitative Test (Chemiluminescence Immunoassay)
Myo Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the myoglobin (Myo) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood, mainly used for auxiliary diagnosis of cardiac diseases.
Malaria P.f/Pan Antigen Rapid Qualitative Test
Malaria P.f/Pan Antigen Rapid Test
The Malaria P.f/Pan Antigen Rapid Test is a rapid lateral flow immunoassay for the qualitative detection of Histidine-Rich Protein II (HRP-II) specific to Plasmodium falciparum (P.f) and Plasmodium lactate dehydrogenase (pLDH) specific to Plasmodium species (Pan) in human whole blood specimen. It is intended to be used by professionals as a screening test and provides a preliminary test result to aid in the diagnosis of infection with Malaria. For professional in vitro diagnostic use only.
NT-proBNP Rapid Quantitative Test (Chemiluminescence Immunoassay)
NT-proBNP Rapid Quantitative Test (Chemiluminescence Immunoassay)
NT-proBNP Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the N-terminal pro-B-type natriuretic peptide(NT-proBNP) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.
β-HCG Rapid Quantitative Test
β-HCG Rapid Quantitative Test
β-HCG is a fluorescent immunoassay for the quantitative measurement of β-HCG level in human serum and whole blood. This test is performed to help diagnose pregnancy if a woman is to undergo a medical treatment, be placed on certain drugs, or have other testing, such as x-rays, that might harm the developing baby.
Malaria Pf/Pv Antigen Qualitative Rapid Test
Malaria Pf/Pv Antigen Rapid Test
The Malaria P.f/P.v Antigen Rapid Test is a lateral flow immunoassay for the qualitative detection of Histidine-Rich Protein II (HRP-II) specific to Plasmodium falciparum (P.f) and Plasmodium lactate dehydrogenase (pLDH) specific to Plasmodium vivax (P.v) in human whole blood specimen. It is intended to be used by professionals as a screening test and provides a preliminary test result to aid in the diagnosis of infection with Malaria. For professional in vitro diagnostic use only.
Leave A Message

Leave A Message

    Please provide us with the information below, and we'll contact you as soon as possible.

Home

products

about

contact